ONAPGO

APOMORPHINE HYDROCHLORIDE · MDD US Operations, LLC, a subsidiary of Supernus Pharmaceuticals, Inc

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ONAPGO, covering 2025-02-03 to 2025-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:

See pricing